HighTower Advisors
GRTS

HighTower Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

HighTower Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10
Closed -$3K – 3743
2021
Q4 		$3K Buy
+10
New +$111 ﹤0.01% 3226

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HighTower Advisors's GRTS Position: Q2 2024 in Review

HighTower Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 35,250 shares — an estimated $91K sold.

HighTower Advisors first reported a position in GRTS in Q3 2020 and held it in 15 quarters. The position peaked at $352K in Q3 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • HighTower Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • HighTower Advisors sold 35,250 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $91K.
  • HighTower Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • HighTower Advisors's Gritstone bio, Inc. Common Stock position peaked at $352K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.